GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,293,000 | -42.1% | 121,600 | -42.1% | 0.08% | -34.6% |
| Q1 2022 | $9,148,000 | +12.6% | 210,000 | +14.0% | 0.13% | +16.1% |
| Q4 2021 | $8,125,000 | +25.6% | 184,250 | +8.9% | 0.11% | +20.4% |
| Q3 2021 | $6,467,000 | +20.0% | 169,250 | +25.1% | 0.09% | +25.7% |
| Q2 2021 | $5,388,000 | +345.3% | 135,300 | +299.1% | 0.07% | +335.3% |
| Q1 2021 | $1,210,000 | -5.7% | 33,900 | -2.8% | 0.02% | -19.0% |
| Q4 2020 | $1,283,000 | -2.2% | 34,863 | 0.0% | 0.02% | -16.0% |
| Q3 2020 | $1,312,000 | -7.7% | 34,863 | 0.0% | 0.02% | -13.8% |
| Q2 2020 | $1,422,000 | +3850.0% | 34,863 | +3520.2% | 0.03% | +2800.0% |
| Q1 2020 | $36,000 | -20.0% | 963 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $45,000 | +9.8% | 963 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $41,000 | +5.1% | 963 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $39,000 | -2.5% | 963 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $40,000 | +8.1% | 963 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $37,000 | -5.1% | 963 | 0.0% | 0.00% | – |
| Q3 2018 | $39,000 | 0.0% | 963 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $39,000 | +2.6% | 963 | 0.0% | 0.00% | – |
| Q1 2018 | $38,000 | +11.8% | 963 | 0.0% | 0.00% | – |
| Q4 2017 | $34,000 | -12.8% | 963 | 0.0% | 0.00% | – |
| Q3 2017 | $39,000 | -48.7% | 963 | -45.4% | 0.00% | -100.0% |
| Q2 2017 | $76,000 | +2.7% | 1,763 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $74,000 | +100.0% | 1,763 | +83.1% | 0.00% | – |
| Q4 2016 | $37,000 | -11.9% | 963 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $42,000 | 0.0% | 963 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $42,000 | -46.2% | 963 | -50.0% | 0.00% | 0.0% |
| Q1 2016 | $78,000 | -70.1% | 1,926 | -70.2% | 0.00% | -80.0% |
| Q4 2015 | $261,000 | +5.2% | 6,457 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $248,000 | -8.5% | 6,457 | -0.8% | 0.01% | 0.0% |
| Q2 2015 | $271,000 | -10.9% | 6,507 | -1.1% | 0.01% | 0.0% |
| Q1 2015 | $304,000 | -11.1% | 6,581 | -17.8% | 0.01% | -28.6% |
| Q4 2014 | $342,000 | -8.8% | 8,007 | -1.7% | 0.01% | 0.0% |
| Q3 2014 | $375,000 | -17.0% | 8,148 | -3.6% | 0.01% | -22.2% |
| Q2 2014 | $452,000 | +0.2% | 8,448 | 0.0% | 0.01% | -10.0% |
| Q1 2014 | $451,000 | 0.0% | 8,448 | 0.0% | 0.01% | -9.1% |
| Q4 2013 | $451,000 | +6.4% | 8,448 | 0.0% | 0.01% | +22.2% |
| Q3 2013 | $424,000 | +0.5% | 8,448 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $422,000 | – | 8,448 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |